Ephrin Receptor
Ephrin receptor inhibitors target Eph receptors, a family of receptor tyrosine kinases that interact with membrane-bound ephrin ligands. Ephrin signaling is crucial for cell positioning, tissue patterning, and angiogenesis. Dysregulation of this pathway is implicated in cancer, neurodegenerative diseases, and developmental disorders. At CymitQuimica, we provide Ephrin receptor inhibitors to support your research in developmental biology, oncology, and neurobiology.
Read more
ALW-II-49-7
CAS:1135219-23-6
ALW-II-49-7 is a selective and potent inhibitor of EphB2 kinase with an EC50 value of …
Formula:
C21H17F3N4O2
Purity:
99.84%
Color and Shape:
Soild
Molecular weight:
414.38
Ref: TM-T67736
| 1mg | 70.00 € | ||
| 5mg | 164.00 € | ||
| 10mg | 238.00 € | ||
| 25mg | 432.00 € | ||
| 50mg | 636.00 € | ||
| 100mg | 900.00 € | ||
| 500mg | 1,811.00 € | ||
| 1mL*10mM (DMSO) | 175.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
AWL-II-38.3
CAS:1135205-94-5
AWL-II-38.3 is a highly potent EphA3 inhibitor with potent kinase inhibitory activity against EphA3.Cost-effective and …
Formula:
C23H18F3N5O3
Purity:
99.87% - 99.87%
Color and Shape:
Liquid
Molecular weight:
469.42
Ref: TM-T38511
| 1mg | 80.00 € | ||
| 5mg | 171.00 € | ||
| 10mg | 260.00 € | ||
| 25mg | 535.00 € | ||
| 50mg | 763.00 € | ||
| 100mg | 1,056.00 € | ||
| 500mg | 2,118.00 € | ||
| 1mL*10mM (DMSO) | 175.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
UniPR1449
UniPR1449 is an EphA2 receptor antagonist with a KD of 3.8±2.4 μM, which is significant …
Purity:
98%
Ref: TM-T80896
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
NVP-BHG712
CAS:940310-85-0
NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR …
Formula:
C26H20F3N7O
Purity:
97.96%
Color and Shape:
Solid
Molecular weight:
503.48
Ref: TM-T6348
| 1mg | 36.00 € | ||
| 2mg | 57.00 € | ||
| 5mg | 83.00 € | ||
| 10mg | 114.00 € | ||
| 25mg | 212.00 € | ||
| 50mg | 389.00 € | ||
| 100mg | 582.00 € | ||
| 1mL*10mM (DMSO) | 88.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
ALW-II-41-27
CAS:1186206-79-0
ALW-II-41-27 (Eph receptor tyrosine kinase inhibitor), an Eph receptor tyrosine kinase inhibitor, is used for …
Formula:
C32H32F3N5O2S
Purity:
97.01% - 99.52%
Color and Shape:
Solid
Molecular weight:
607.69
Ref: TM-T4344
| 1mg | 68.00 € | ||
| 2mg | 95.00 € | ||
| 5mg | 172.00 € | ||
| 10mg | 258.00 € | ||
| 25mg | 427.00 € | ||
| 50mg | 629.00 € | ||
| 100mg | 889.00 € | ||
| 1mL*10mM (DMSO) | 239.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ehp-inhibitor-2
CAS:861249-77-6
Ehp-inhibitor-2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.
Formula:
C17H13N5O
Purity:
98.02%
Color and Shape:
Solid
Molecular weight:
303.32
Ref: TM-T5452
| 1mg | 46.00 € | ||
| 2mg | 58.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 151.00 € | ||
| 25mg | 246.00 € | ||
| 50mg | 365.00 € | ||
| 100mg | 538.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
123C4
CAS:2034159-30-1
123C4 is a potent, selective and competitive agonist of the receptor tyrosine kinase EPHA4 (Ki=0.65 …
Formula:
C43H47ClN8O6
Purity:
98.94%
Color and Shape:
Solid
Molecular weight:
807.34
Ref: TM-TP1561
| 1mg | 142.00 € | ||
| 5mg | 305.00 € | ||
| 10mg | 500.00 € | ||
| 25mg | 799.00 € | ||
| 50mg | 1,068.00 € | ||
| 100mg | 1,445.00 € | ||
| 1mL*10mM (DMSO) | 503.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Tesevatinib
CAS:781613-23-8
Tesevatinib (XL-647) is an oral, multi-targeted tyrosine kinase inhibitor.Cost-effective and quality-assured.
Formula:
C24H25Cl2FN4O2
Purity:
97.89% - 97.89%
Color and Shape:
Solid
Molecular weight:
491.39
Ref: TM-TQ0166
| 1mg | 107.00 € | ||
| 2mg | 152.00 € | ||
| 5mg | 237.00 € | ||
| 10mg | 458.00 € | ||
| 25mg | 749.00 € | ||
| 50mg | 1,025.00 € | ||
| 1mL*10mM (DMSO) | 256.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Eph inhibitor 2
CAS:861249-59-4
Eph inhibitor 2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.
Formula:
C18H15N5O
Purity:
99.01%
Color and Shape:
Solid
Molecular weight:
317.34
Ref: TM-T5451
| 1mg | 95.00 € | ||
| 2mg | 122.00 € | ||
| 5mg | 186.00 € | ||
| 10mg | 280.00 € | ||
| 25mg | 509.00 € | ||
| 50mg | 734.00 € | ||
| 100mg | 1,023.00 € | ||
| 500mg | 2,034.00 € | ||
| 1mL*10mM (DMSO) | 185.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
NVP-BHG712 isomer
CAS:2245892-85-5
NVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4.
Formula:
C26H20F3N7O
Purity:
99.65%
Color and Shape:
Solid
Molecular weight:
503.48
Ref: TM-T19487
| 1mg | 43.00 € | ||
| 2mg | 55.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 147.00 € | ||
| 25mg | 255.00 € | ||
| 50mg | 368.00 € | ||
| 100mg | 547.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
JI-101
CAS:900573-88-8
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets VEGFR-2, PDGFR-β, and EphB4.
Formula:
C22H20BrN5O2
Purity:
99.35% - 99.41%
Color and Shape:
Solid
Molecular weight:
466.33
Ref: TM-T3476
| 1mg | 36.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 110.00 € | ||
| 25mg | 185.00 € | ||
| 50mg | 299.00 € | ||
| 100mg | 467.00 € | ||
| 1mL*10mM (DMSO) | 86.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
UniPR505
CAS:2938227-14-4
UniPR505 is a potent EphA2 antagonist (IC50: 0.95 µM), a novel 3α-carbamoyloxy derivative with antiangiogenic …
Formula:
C39H57N3O5
Purity:
99.23%
Color and Shape:
Liquid
Molecular weight:
647.89
Ref: TM-T73368
| 1mg | 493.00 € | ||
| 5mg | 1,087.00 € | ||
| 25mg | 1,825.00 € | ||
| 50mg | 2,209.00 € | ||
| 100mg | 2,890.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025
UniPR1447
CAS:1809170-68-0
UniPR1447 is a dual antagonist for both EphA2 and EphB2 receptors, exhibiting an IC50 value …
Formula:
C36H50N2O4
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
574.79
Ref: TM-T80897
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
